肠促胰岛素系统——治疗2型糖尿病的新动向  

Incretin system——a new trend for treatment of type 2 diabetes

作　　者：于宏梅[1] 陈万春[2] 金惠根[1] 陶春燕[1] 

机构地区：[1]上海中医药大学附属普陀医院心内科,上海200062 [2]上海交通大学附属第六人民医院心内科,上海200233

出　　处：《世界临床药物》2009年第5期304-305,311,共3页World Clinical Drug

摘　　要：随着2型糖尿病发病率的逐年增加,临床出现了多种治疗2型糖尿病的新药,其中肠促胰岛素系统相关药物备受关注。本文简要介绍肠促胰岛素系统相关药物。In recent years, many kinds of new drugs for the treatment of type 2 diabetes have been developed followed the increasing morbidity of type 2 diabetes, among which incretin system related drugs obtained great attention. This article reviewed the development of incretin system related drugs.

关 键 词：肠促胰岛素 胰高血糖素 肽 糖尿病 非胰岛素依赖型 

分 类 号：R977.15[医药卫生—药品]